SCHEMBL9093812

SCHEMBL9093812

Cc1oncc1C(=O)SNc1ccc(C(F)(F)F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.67
▸ RAB9A P51151 3/20 0.67
▸ NPC1 O15118 2/20 0.67
▸ HTT P42858 2/20 0.67
▸ GMNN O75496 1/20 0.67
▸ LMNA P02545 1/20 0.67
▸ TP53 P04637 1/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ HTR1A P08908 1/20 0.67
▸ THRB P10828 1/20 0.67
▸ PIM1 P11309 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ MAOA P21397 1/20 0.67
▸ SLC6A2 P23975 1/20 0.67
▸ HTR2A P28223 1/20 0.67
▸ AGTR1 P30556 1/20 0.67
▸ CCKBR P32239 1/20 0.67
▸ MC4R P32245 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leflunomide SCHEMBL1243495 0.80 RAB9A (1.00) DHODHRAB9ANPC1HTTGMNN
Leflunomide SCHEMBL5057 0.80 RAB9A (1.00) DHODHRAB9ANPC1HTTGMNN
SCHEMBL7459817 0.78 DHODH (0.76) DHODHRAB9ANPC1HTTGMNN
Leflunomide SCHEMBL29271960 0.77 RAB9A (0.92) DHODHRAB9ANPC1HTTGMNN
SCHEMBL11320933 0.77 DHODH (0.67) DHODHRAB9ANPC1HTTGMNN
SCHEMBL9114519 0.75 DHODH (0.64) DHODHRAB9ANPC1HTTGMNN
SCHEMBL11428900 0.75 RAB9A (0.88) DHODHRAB9ANPC1HTTGMNN
SCHEMBL8484731 0.75 DHODH (0.71) DHODHRAB9ANPC1HTTGMNN
SCHEMBL8812525 0.74 RAB9A (0.86) DHODHRAB9ANPC1HTTGMNN
Leflunomide SCHEMBL18584841 0.73 RAB9A (0.84) DHODHRAB9ANPC1HTTGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996033179-A1 THIOAMIDES DERIVATES AND THEIR USE AS INHIBITORS OF HYPER-PROLIFERATIVE CELL GROWTH SUGEN, INC. (US) 1996-10-24 — — WO disclosed
Send feedback